August 5, 2021
Neuropsychotropic Drug Therapy 2019 | Drug-Induced Movement Disorders
Neuropsychotropic Drug Therapy 2019
Drug-Induced Movement Disorders
Kimmy Su, MD
Fellow, Movement Disorders, VA Puget Sound Health Care System, Seattle, WA
For psychiatric nurse practitioners, clinical nurse specialists, nurses, pharmacists and other interested healthcare professionals.
Objectives for Learning Outcomes
At the conclusion of this activity, participants will be better able to:
- Know the basic understanding of drug-induced movement disorders.
- Describe the general approach to workup and management of tremors.
- Discuss the general approach to management of tardive dyskinesia.